CBIZ (CBZ) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
25 Feb, 2026Executive summary
Achieved 52% year-over-year revenue growth in 2025, primarily driven by the Marcum acquisition and successful integration, with approximately 2% organic growth amid soft market conditions and post-merger productivity losses.
Adjusted Diluted EPS for 2025 was $3.61, in line with guidance, and net income rose 181.3% to $115.4M.
Integration of Marcum largely completed, unlocking synergies double initial expectations and positioning for sustainable long-term growth.
Strategic focus for 2026 includes talent acquisition, brand elevation, industry specialization, cross-serving, and expanded service offerings.
Investments in AI, automation, and offshoring are expected to enhance efficiency, client experience, and profitability.
Financial highlights
Full-year revenue reached $2.8B in 2025, up from $1.81B in 2024, with fourth quarter revenue at $543M.
Adjusted EBITDA for 2025 was $447M (16.2% margin), up 125.5% year-over-year, with a margin increase of 530 basis points.
Adjusted EPS for 2025 was $3.61, up 79.6% year-over-year.
Free cash flow rose to $176M, with conversion at 40% due to integration costs.
Repurchased 2.5M shares for $168M; board authorized up to 5M additional repurchases.
Outlook and guidance
2026 revenue expected between $2.8B and $2.9B, representing 2%-5% growth, with project-based work as the main variable.
Adjusted EBITDA guidance is $450M-$460M; adjusted EPS expected at $3.75-$3.85.
Free cash flow projected at $270M-$290M, with ~60% conversion at the midpoint.
Integration costs in 2026 expected at $70M-$80M, with capital expenditures elevated due to facility optimization.
Effective tax rate expected at 28.5%; diluted share count ~62M.
Latest events from CBIZ
- Q2 revenue up 5.4%; $2.3B Marcum deal to close Q4, creating a top-7 U.S. accounting provider.CBZ
Q2 20242 Feb 2026 - Balanced organic and acquisition-driven growth, high retention, and margin expansion drive outperformance.CBZ
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Q3 adjusted EPS up 27.3% and Marcum acquisition completed, boosting scale and leverage.CBZ
Q3 202418 Jan 2026 - Acquisition of Marcum creates a top-7 firm, boosting scale, recurring revenue, and growth prospects.CBZ
Sidoti Small-Cap Virtual Investor Conference11 Jan 2026 - Q1 2025 revenue up 69.5% to $838M, adjusted EBITDA doubled, Marcum integration on track.CBZ
Q1 202525 Dec 2025 - 2025 guidance: $2.90–$2.95B revenue, $3.60–$3.65 adjusted EPS, $450M–$456M EBITDA.CBZ
Q4 202421 Dec 2025 - Shareholders to vote on $2.3B Marcum acquisition, with major stock issuance and board changes.CBZ
Proxy Filing1 Dec 2025 - Proxy covers director elections, auditor ratification, say-on-pay, and robust governance disclosures.CBZ
Proxy Filing1 Dec 2025 - Shareholders to vote on a $2.3B merger with Marcum LLP, adding 22% new shares and board representation.CBZ
Proxy Filing1 Dec 2025